Retinoblastoma management during the COVID‐19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries

Ido Didi Fabian; Andrew W. Stacey; Richard Bowman; Vikas Khetan; Sharon Blum; Naama Keren-Froim; Sandra Staffieri; Allen Foster; the Global Retinoblastoma Study Group; HIND M ALKATAN

doi:10.1002/pbc.28584

Back

Retinoblastoma management during the COVID‐19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries

Journal article

Peer reviewed

Retinoblastoma management during the COVID‐19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries

Ido Didi Fabian, Andrew W. Stacey, Richard Bowman, Vikas Khetan, Sharon Blum, Naama Keren-Froim, Sandra Staffieri, Allen Foster, the Global Retinoblastoma Study Group and HIND M ALKATAN

Pediatric blood & cancer, Vol.68(1), pp.e28584-n/a

01/2021

DOI: https://doi.org/10.1002/pbc.28584

PMCID: 7435529

PMID: 32762025

Metrics

1 Record Views

See more details

Details

Title: Retinoblastoma management during the COVID‐19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries
Creators - without role: Ido Didi Fabian - Tel Aviv University
Andrew W. Stacey - University of Washington
Richard Bowman - Great Ormond Street Hospital
Vikas Khetan - Sankara Nethralaya
Sharon Blum - Sheba Medical Center
Naama Keren-Froim - Tel Aviv University
Sandra Staffieri - Royal Children's Hospital
Allen Foster - London School of Hygiene & Tropical Medicine
the Global Retinoblastoma Study Group
HIND M ALKATAN - King Saud University
Publication Details: Pediatric blood & cancer, Vol.68(1), pp.e28584-n/a
Identifiers: 9948104208331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article